BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
MDM2
,
Apoptosis
,
Allergy to pollen
,
Kidney
,
Amniocentesis
,
Prozac
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
receptors antigen, b- cell
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Embryonic kidney epithelial HA1E cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Actinin-4 controls survival signaling in B cells by limiting the lateral mobility of B-cell antigen …
Identification of unique molecular heterogeneity of human CD79, the signaling component of the human…
Plasma membrane topography governs the 3D dynamic localization of IgM B cell antigen receptor cluste…
Structural principles of B cell antigen receptor assembly.
Abelson tyrosine kinase controls BCR signalling and B-cell differentiation by promoting B-cell metab…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell Malignancies
Chimeric Antigen Receptor T Cells (CART) Therapy in Refractory/Relapsed B Cell Hematologic Malignanc…
To Observe the Dual-target Chimeric Antigen Receptor T Cells in the Treatment of B Cell Hematologic …
Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malig…
ENABLE (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ